Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod
Mumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim's SPEVIGO (spesolimab) injection, a first-in-class treatment for generalised pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, …